addition, we used the following ICD codes to identify patients with screening encounters: Z12.31, V76.11, and V76.12. Statistical Analysis We compared clinical and tumor characteristics between women diagnosed with cancer who received screening
Search Results
Marissa B. Lawson, Christoph I. Lee, Daniel S. Hippe, Shasank Chennupati, Catherine R. Fedorenko, Kathleen E. Malone, Scott D. Ramsey, and Janie M. Lee
Jordan M. Cloyd, Chengli Shen, Heena Santry, John Bridges, Mary Dillhoff, Aslam Ejaz, Timothy M. Pawlik, and Allan Tsung
,500 Commission on Cancer–accredited facilities. Jointly sponsored by the American College of Surgeons and American Cancer Society, it currently captures more than 70% of newly diagnosed cancers within the United States. Relevant patient characteristics, tumor
Angela Pecoraro, Giuseppe Rosiello, Stefano Luzzago, Marina Deuker, Franciska Stolzenbach, Zhe Tian, Shahrokh F. Shariat, Fred Saad, Alberto Briganti, Anil Kapoor, Cristian Fiori, Francesco Porpiglia, and Pierre I. Karakiewicz
data can provide further detail regarding the distribution of patient and renal cell carcinoma (RCC) characteristics within this special patient group. Based on these considerations, we reexamined patients with RCC with T1a 0- to 2-cm renal tumors to
Amit G. Singal, Jorge A. Marrero, and Adam Yopp
characteristics could not be determined. Patients with Child-Pugh C cirrhosis and those with poor performance status were also excluded, because surveillance is not recommended in these patients. This study was approved by the Institutional Review Board at UT
Stephen R. Grant, Benjamin D. Smith, Lauren E. Colbert, Qunyh-Nhu Nguyen, James B. Yu, Steven H. Lin, and Aileen B. Chen
(1) assess the frequency of quality measure–concordant radiation for bone metastases as per NQF 1822; (2) describe variation in compliance by tumor, patient, and treatment characteristics; and (3) explore and consider the value, shortcomings, and
Angel Qin, Songzhu Zhao, Abdul Miah, Lai Wei, Sandipkumar Patel, Andrew Johns, Madison Grogan, Erin M. Bertino, Kai He, Peter G. Shields, Gregory P. Kalemkerian, Shirish M. Gadgeel, Nithya Ramnath, Bryan J. Schneider, Khaled A. Hassan, Nicholas Szerlip, Zoey Chopra, Sara Journey, Jessica Waninger, Daniel Spakowicz, David P. Carbone, Carolyn J. Presley, Gregory A. Otterson, Michael D. Green, and Dwight H. Owen
approved by the Institutional Review Boards of both institutions. Patient demographics, disease characteristics (stage, histology, genomic alterations, metastatic burden [defined as the number of metastatic organ systems involved: 1, 2, ≥2]), treatment
Grace E. McKay, Anna L. Zakas, Fauzia Osman, and Amanda Parkes
metastatic cancer at time of diagnosis, receipt of chemotherapy, and documentation of a genetics discussion with an oncology provider. Statistical Analysis Patient characteristics were recorded as percentages for categorical variables and as means and
Lisa I. Iezzoni, Sowmya R. Rao, Nicole D. Agaronnik, and Areej El-Jawahri
) age at cancer diagnosis for persons with versus without preexisting disability, and (4) associations between cancer diagnosis and preexisting disability after adjusting for sociodemographic characteristics and selected risk factors. Methods Data We
Lydia T. Madsen, Deborah A. Kuban, Seungtaek Choi, John W. Davis, Jeri Kim, Andrew K. Lee, Delora Domain, Larry Levy, Louis L. Pisters, Curtis A. Pettaway, John F. Ward, Christopher Logothetis, and Karen E. Hoffman
conducted using SAS 9.2 (Cary, North Carolina). Results Patient Characteristics A total of 1370 men with localized prostate cancer were seen at the MPCC between 2004 and 2008 and subsequently received treatment at MD Anderson. The median age at
Gary S. Rogers
reported on the use of a hematoporphyrin derivative to treat a person with metastatic chest wall breast cancer. Table 1 lists the characteristics of 3 photosensitizers: porfimer sodium (Photofrin), 5-aminolevulinic acid (ALA), and mTHPC ( meso -tetra
